scPharmaceuticals Inc (SCPH)
4.06
+0.03
(+0.74%)
USD |
NASDAQ |
Nov 05, 16:00
4.06
0.00 (0.00%)
After-Hours: 16:18
scPharmaceuticals Profit Margin (Quarterly): -212.2% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -212.2% |
| March 31, 2024 | -231.2% |
| December 31, 2023 | -226.6% |
| Date | Value |
|---|---|
| September 30, 2023 | -411.9% |
| June 30, 2023 | -864.1% |
| March 31, 2023 | -543.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-864.1%
Minimum
Jun 2023
-212.2%
Maximum
Jun 2024
-414.9%
Average
-321.5%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -165.1% |
| Return on Assets | -66.11% |
| Return on Invested Capital | -80.26% |
| Gross Profit Margin (Quarterly) | 71.44% |
| Operating Margin (Quarterly) | -179.2% |
| Return on Net Operating Assets | -355.0% |